Anju Software Enters the Clinical Trial Software Segment by Acquisition of ClinPlus
CHICAGO–(BUSINESS WIRE)–Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired the assets of ClinPlus, a division of DZS Software Solutions, Inc.
“ClinPlus has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting. With this complete product suite, Anju can provide full clinical trial software support from Phase 1 to Phase 4 with a scalable web platform for CROs and pharma companies,” said Kurien Jacob, CEO of Anju Software. Jacob also added that the acquisition of ClinPlus is consistent with Anju’s strategy of continuing to enhance its product offering through acquisitions and internal development.Read More